Seifert R, Borchert W, Letendre P, Knutson R, Cipolle R
Ther Drug Monit. 1986;8(1):32-6.
A method to assess heparin kinetics and individualize dosages was examined in 27 patients during chronic hemodialysis. Pretreatment heparin sensitivities were determined to establish the relationship between heparin concentration and activated clotting times (ACTs). Distribution volume was calculated by dividing the heparin loading dose by the 5-min heparin concentration. Assessments were made during three different dialysis periods. There was a 10-fold range in pretreatment heparin sensitivities. Intrapatient heparin sensitivity remained relatively consistent between dialysis periods. The degree of heparin sensitivity was significantly correlated to baseline ACT. Patients post-splenectomy were more sensitive to heparin. Large intra- and interpatient variation in distribution volume was also observed. Men, patients less than 60 years old, and patients post-splenectomy represented variables that contributed to higher heparin dose requirements.
在27例慢性血液透析患者中研究了一种评估肝素动力学和个体化剂量的方法。通过测定治疗前肝素敏感性来建立肝素浓度与活化凝血时间(ACT)之间的关系。分布容积通过肝素负荷剂量除以5分钟时的肝素浓度来计算。在三个不同的透析阶段进行评估。治疗前肝素敏感性有10倍的范围。患者在透析阶段之间的肝素敏感性保持相对一致。肝素敏感性程度与基线ACT显著相关。脾切除术后患者对肝素更敏感。还观察到分布容积在患者内和患者间有很大差异。男性、年龄小于60岁的患者以及脾切除术后患者是导致肝素剂量需求更高的变量。